Blood Borne Virus Screening O O O

“Preventing the spread of blood-borne diseases is a major goal of drug treatment services and a major contribution to individual and public health. Helping drug misusers who are already infected to become aware of their condition, to reduce harm, and maintain their health is an essential part of drug treatment services.” (Models of Care, Part 2, Department of Health 2002).

Our service utilises the latest and most cost-effective products available. Screening has moved on. No longer is it essential to obtain a blood sample each time in order to identify infection - a very real advantage with needle shy, high risk groups.

The OraSure^® system involves a quick and simple process of OMT collection that can be undertaken by any trained member of staff, almost anywhere.

We offer screening for Chlamydia Trachomatis via a non-invasive urine sample.